# Pilocarpine After Combined Cataract/Trabectome Surgery

> **NCT04005079** · PHASE3 · WITHDRAWN · sponsor: **Montefiore Medical Center**

## Conditions studied

- Open Angle Glaucoma
- Ocular Hypertension

## Interventions

- **DRUG:** Pilocarpine
- **DRUG:** Ofloxacin
- **DRUG:** Prednisolone

## Key facts

- **NCT ID:** NCT04005079
- **Lead sponsor:** Montefiore Medical Center
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2019-06-05
- **Primary completion:** 2021-01-21
- **Final completion:** 2021-01-21
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** not performing Trabectomes
- **Last updated:** 2022-04-07


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04005079

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04005079, "Pilocarpine After Combined Cataract/Trabectome Surgery". Retrieved via AI Analytics 2026-06-12 from https://api.ai-analytics.org/clinical/NCT04005079. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*